EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention

Li Zhuang, Ling Yang, Linsheng Li, Zhaoyang Ye, Wenping Gong iD

MedComm · 2024-01 · 5 (1)

DOI: 10.1002/mco2.419 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 06.01.2024. Verfasst von Li Zhuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment Senior Department of Tuberculosis, the Eighth Medical Center of PLA …. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 274 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although tuberculosis (TB) is an infectious disease, the progression of the disease following Mycobacterium tuberculosis (MTB) infection is closely associated with the host's immune response. In this review, a comprehensive analysis of TB prevention, diagnosis, and treatment was conducted from an immunological perspective. First, we delved into the host's immune response mechanisms against MTB infection as well as the immune evasion mechanisms of the bacteria. Addressing the challenges currently faced in TB diagnosis and treatment, we also emphasized the importance of protein, genetic, and immunological biomarkers, aiming to provide new insights for early and personalized diagnosis and treatment of TB. Building upon this foundation, we further discussed intervention strategies involving chemical and immunological treatments for the increasingly critical issue of drug‐resistant TB and other forms of TB. Finally, we summarized TB prevention, diagnosis, and treatment challenges and put forward future perspectives. Overall, these findings provide valuable insights into the immunological aspects of TB and offer new directions toward achieving the WHO's goal of eradicating TB by 2035.

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiagnostic methodsimmune checkpointsimmune responsemycobacterium tuberculosis (MTB)therapeutic vaccinestuberculosis (TB)

Autor:innen und Institutionen

  • Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment Senior Department of Tuberculosis, the Eighth Medical Center of PLA General Hospital Beijing China.
  • Senior Department of Tuberculosis Hebei North University Zhangjiakou Hebei China.

ORCID-Profile: Wenping Gong

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhuang, L., Yang, L., Li, L., Ye, Z., & Gong, W. (2024). Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention. MedComm, 5(1). https://doi.org/10.1002/mco2.419

Vancouver

Zhuang L, Yang L, Li L, Ye Z, Gong W. Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention. MedComm. 2024;5(1). doi:10.1002/mco2.419

BibTeX
@article{Zhuang2024,
  author = {Zhuang, Li and Yang, Ling and Li, Linsheng and Ye, Zhaoyang and Gong, Wenping},
  title = {Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {1},
  doi = {10.1002/mco2.419}
}
Kostenlos starten →